Factor X (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Factor X" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2web.archive.org

1^st place

1^st place

2^nd place

7^th place

1pharmaxchange.info

low place

3,229^th place

79^th place

313^th place

low place

low place

447^th place

749^th place

6^th place

8^th place

archive.org

Turpie AG (June 2007). "Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases". Arteriosclerosis, Thrombosis, and Vascular Biology 27 (6): 1238–47. PMID 17379841. doi:10.1161/ATVBAHA.107.139402.

bpl.co.uk

"BPL Announces: Strong progress on the world's first licensed Factor X product" (Nota de prensa). Bio Products Laboratory. August 10, 2015. Arquivado dende o orixinal o 23 de setembro de 2015. Consultado o October 21, 2015.

doi.org

dx.doi.org

Hoffman M, Monroe DM (February 2007). "Coagulation 2006: a modern view of hemostasis". Hematology/Oncology Clinics of North America 21 (1): 1–11. PMID 17258114. doi:10.1016/j.hoc.2006.11.004.
Turpie AG (June 2007). "Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases". Arteriosclerosis, Thrombosis, and Vascular Biology 27 (6): 1238–47. PMID 17379841. doi:10.1161/ATVBAHA.107.139402.

fda.gov

"FDA approves first Factor X concentrate to treat patients with rare hereditary bleeding disorder" (Nota de prensa). US FDA. October 20, 2015. Consultado o October 21, 2015. Until today’s orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.

nih.gov

ncbi.nlm.nih.gov

Hoffman M, Monroe DM (February 2007). "Coagulation 2006: a modern view of hemostasis". Hematology/Oncology Clinics of North America 21 (1): 1–11. PMID 17258114. doi:10.1016/j.hoc.2006.11.004.
Turpie AG (June 2007). "Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases". Arteriosclerosis, Thrombosis, and Vascular Biology 27 (6): 1238–47. PMID 17379841. doi:10.1161/ATVBAHA.107.139402.
Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP (February 1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action". Blood 71 (2): 335–43. PMID 3422166.

pharmaxchange.info

"Presentation on Direct Factor Xa Inhibitors". Arquivado dende o orixinal o 03 de marzo de 2016. Consultado o 02 de setembro de 2018.

web.archive.org

"Presentation on Direct Factor Xa Inhibitors". Arquivado dende o orixinal o 03 de marzo de 2016. Consultado o 02 de setembro de 2018.
"BPL Announces: Strong progress on the world's first licensed Factor X product" (Nota de prensa). Bio Products Laboratory. August 10, 2015. Arquivado dende o orixinal o 23 de setembro de 2015. Consultado o October 21, 2015.

wsj.com

Ron Winslow; Avery Johnson (2007-12-10). "Race Is on for the Next Blood Thinner". Wall Street Journal. p. A12. Consultado o 2008-01-06. Este grande interese reflicte a maior comprensión do que os doutores chaman a fervenza de coagulación... Catro novos anticoagulantes teñen como diana este encima chamado factor Xa, un dos varios encimas que xogan un importante papel na fervenza.